Member Info for dallo

While this is good news on Puretech's anxiety drug , it is still only a Phase 2(A) trial result so a long way to go.

This is not the news the market is waiting for .

It is clarification on the capital reallocation and potential large return of excess capital to shareholders.

I am expecting this to be announced, as promised by the company, within the next 2/3 weeks.

This has the potential to drive the share price to nearer true values of c £4 plus.

DYOR

Not to mention that if Puretech puts its own drug therapies into new foundation companies, it frees up it own cash pile of c$400m for distribution to shareholders.

Totally and utterly undervalued imho.

Puretech could garner from Karuna, I should say.

Drew

Yes

Puretech are set to announce a capital reallocation plan possibly involving a return to shareholders of a large special dividend and the establishment of new foundation companies to incorporate its own in-house drug therapies.

It looks like Puretech is moving to a royalties/ milestone payments operation and will extract value from Karuna and Vedanta over the coming months.

Karuna could garner c $250m from Puretech's shareholding plus $ $400m from royalties sale.

Vedanta could unlock another another c$500m from its 42% shareholding plus additional funds from royalties and other payments.

Shareholder pressure is driving this change of strategy particularly from Invesco who have 24% of the company.

It could be very exciting.

Read the previous RNS from Puretech to see what it intimated was its plan.

ATB

Trading again

170p

The Sets will be working overtime to clear todays backlog

Kerching

I was thinking the very same thing

No RNS from Puretech or LSE disruption notifications so no obvious reasons for no trades.

Bizarre

Machin

I am crazy too...picked up another 100k at 1.7p

ATB

After I contacted her, I should say

Wildbunch

I think it was changed very recently.

Also Lisa is making further changes to the website today after contacted regarding some poor and repetitive wording.

She confirmed the company hopes to update the market on the progress of the Lupuzor trials " in the near future".

Make of that as you will!

Wildbunch

Go to website...then Investors...scroll down to 4 key products..then you will see Lupuzor...trial start date 2023/24.

50,000 buy of mine appears late as a sell at 1.7p.

Also I have emailed Lisa to signal our impatience on the lack of newsflow and also to ask her to amend Paragraph 2 under Investors on the Website as it repeats Paragraph 1....very shoddy indeed.

Lambo

In fairness the website didn't say delayed until 2024 just trial to commence 2023/2024 albeit 2023 is fast disappearing.

The only consolation is that Alora/Avion are still on board unless we hear otherwise

I am still 350,000 shy of my 500 ,000 buy order so not much selling going on at these near all time low levels

Cauldstream

For what it is worth , Immupharma ,on its website, is stating that the Lupuzor Phase 2/3 trial will start in 2023/2024.

So small delay is possible but what's new!

_

Machin

Thanks for that particularly from another long suffering investor.

I am seriously under water with 2.6m at c11p average so not feeling very smart but we are not dead yet even though Uncle Tim would frustrate a vicar .

Confirmation of the start of the Lupuzor trial and Alora/Avion continued commitment plus any other positive newsflow will really boost the share price .

As usual Mc Carthy will keep us all waiting although in fairness he is probably dependent on the actions of Avion in respect of the trial start.

Maybe next week!!!

Lambo

Got 100k filled at 1.7p.

My Broker is Cantor Fitzgerald.

Lord

Fully agree with you on your points but as someone here for 8 years I just wanted to see from other posters had they difficulty in filling buy orders.

Nothing more .

Machin

Best of luck.

I cannot get the 500,000 at 1.75p.

MMs quoting 1.90p for this amount but I am holding firm.

They may relent later as we near the close

Correction..

Puretech has now 41% of Vedanta Therapeutics following the c $110m financing round in April this year which valued Vedanta at over $1.5b.

Angel

I have added another 50,000 shares this week to bring my holdings to 100,000 .

Karuna is a jewel in the crown once the FDA approves its blockbuster Schizophrenia drug, releasing another $400m from the royalties buyer, milestone payments as well as its 2.8% equity stake which could be worth c$250m. Vedanta could be the next major winner and backed by Pfizer and the likes of the Gates Foundation and where Puretech has a 48% equity stake and royalties etc.

Reading the last RNS update you will note Puretech is to announce major news soon on capital allocation and perhaps establishing new Foundation companies for its own in house drug therapies with a major return via a special dividend to shareholders hinted at.

Zohar is consulting with major shareholders including Invesco who hold 23% of the shares on best strategy on this proposal which could be announced at the fire side conferences in 2/3 weeks.

Interesting few weeks ahead

Dyor

ATB

Mcco,

Not me ..I am still on 500k at 1.75p and not done as yet.

Pokerchips

Agreed

If there is an issue with Alora/Avion then Immupharma must inform the market immediately.

Anyway I have an order to buy 500,000 at 1.75p since 10am which would bring my total holdings to 3m.

Not been filled as yet.

Having witnessed the unbelievable events in Ethernity over the past week where the SP moved from .25p to 4.7p today , a rise of c4.5p or 1,800% , here's hoping the Tiktok herd discover Immupharma!!!